Neurocrine Biosciences (NBIX) Other Operating Expenses (2010 - 2026)
Neurocrine Biosciences (NBIX) posted quarterly Other Operating Expenses of $28.6 million for Q1 2026, down 17.34% on a QoQ basis from $34.6 million in Q4 2025.
Neurocrine Biosciences (NBIX) Other Operating Expenses (2010 - 2026) Analysis & Trends
Neurocrine Biosciences has reported Other Operating Expenses for 16 years, with the latest figure at $28.6 million in Q1 2026.
- Other Operating Expenses for Q1 2026 came in at $28.6 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2026 was $77.5 million (up 263.85% YoY), and the FY2025 annual result was $69.5 million, up 49.46% from the prior year.
- Other Operating Expenses retreated to $28.6 million in Q1 2026, from $34.6 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $187.8 million in Q2 2024 and troughed at $6.1 million in Q3 2022.
- A 5-year average of $57.5 million and a median of $14.3 million in 2025 frame the typical range for Other Operating Expenses.
- The largest YoY upside for Other Operating Expenses was 3331.03% in 2022 against a maximum downside of 92.62% in 2022.
- A 5-year view of Other Operating Expenses shows it stood at $7.7 million in 2022, then increased by 10.39% to $8.5 million in 2023, then soared by 44.71% to $12.3 million in 2024, then jumped by 181.3% to $34.6 million in 2025, then declined by 17.34% to $28.6 million in 2026.
- Per Business Quant data, the three most recent Other Operating Expenses figures were $28.6 million in Q1 2026, $34.6 million in Q4 2025, and $14.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Alkermes | 8.19 Bn | 7.53 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.60 Mn |
| Dec 31, 2025 | 34.60 Mn |
| Sep 30, 2025 | 14.30 Mn |
| Jun 30, 2025 | 240.60 Mn |
| Dec 31, 2024 | 12.30 Mn |
| Sep 30, 2024 | 9.00 Mn |
| Jun 30, 2024 | 195.30 Mn |
| Mar 31, 2024 | 167.90 Mn |
| Dec 31, 2023 | 8.50 Mn |
| Sep 30, 2023 | 11.20 Mn |
| Jun 30, 2023 | 11.50 Mn |
| Mar 31, 2023 | 152.40 Mn |
| Dec 31, 2022 | 7.70 Mn |
| Sep 30, 2022 | 6.10 Mn |
| Jun 30, 2022 | 110.70 Mn |
| Mar 31, 2022 | 99.50 Mn |
| Dec 31, 2021 | 104.40 Mn |
| Sep 30, 2021 | 4.20 Mn |
| Jun 30, 2021 | 8.10 Mn |
| Mar 31, 2021 | 2.90 Mn |